Effects of intra-tumoral cellular heterogeneity of oxygen partial pressure on biological effectiveness of hydrogen-, helium-, carbon-, oxygen-, and neon-ion beams
- 16 January 2025
- journal article
- research article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (2) , 025008
Abstract
Objective. The tumor microenvironment characterized by heterogeneously organized vasculatures causes intra-tumoral heterogeneity of oxygen partial pressure p at the cellular level, which cannot be measured by current imaging techniques. The intra-tumoral cellular p heterogeneity may lead to a reduction of therapeutic effects of radiation. The purpose of this study was to investigate the effects of the heterogeneity on biological effectiveness of H-, He-, C-, O-, and Ne-ion beams for different oxygenation levels, prescribed dose levels, and cell types. Approach. The intra-tumoral cellular p distributions were simulated with a numerical tumor model for average oxygen pressures p ¯ t ranging from 2.5 to 15 mmHg. The relative biological effectiveness (RBE)-weighted dose distributions of 3–15 Gy prescribed doses were planned for a cuboid target with the five ion species for constant p ¯ t values. Radiosensitivities of human salivary gland tumor (HSG) and Chinese hamster ovary (CHO) cells were investigated. The planned dose distributions were then recalculated by taking the p heterogeneity into account. Main results. As p ¯ t decreased and prescribed dose increased, the biological effectiveness of the ion beams decreased due to the p heterogeneity. The reduction in biological effectiveness was pronounced for lighter H- and He-ion beams compared to heavier C-, O-, and Ne-ion beams. The RBE-weighted dose in the target for HSG (CHO) cells decreased by 41.2% (44.3%) for the H-ion beam, while it decreased by 16.7% (14.7%) for the Ne-ion beam at a prescribed dose of 15 Gy under a p ¯ t of 2.5 mmHg. Significance. The intra-tumoral cellular p heterogeneity causes a significant reduction in biological effectiveness of ion beams. These effects should be considered in estimation of therapeutic outcomes.Keywords
Funding Information
- Exploratory Research for Advanced Technology (JPMJER2102)
- the Japan Society for Promotion of Science (JSPS) KAKENHI Grant-in Aid for Scientific Research (24 K10773)
- the Japan Society of Medical Physics
This publication has 52 references indexed in Scilit:
- Dose-averaged LET optimized carbon-ion radiotherapy for head and neck cancersRadiotherapy and Oncology, 2024
- Stopping-power ratio of body tissues with updated effective energies and elemental I values for treatment planning of proton therapy and ion beam therapy with helium, carbon, oxygen, and neon ionsRadiological Physics and Technology, 2023
- Kill-painting of hypoxic tumours in charged particle therapyScientific Reports, 2015
- FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trialRadiotherapy and Oncology, 2012
- Hypofractionation Results in Reduced Tumor Cell Kill Compared to Conventional Fractionation for Tumors With Regions of HypoxiaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Adapting radiotherapy to hypoxic tumoursPhysics in Medicine & Biology, 2006
- The relationship between temporal variation of hypoxia, polarographic measurements and predictions of tumour response to radiationPhysics in Medicine & Biology, 2004
- Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxiaPhysics in Medicine & Biology, 2003
- Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- A convenient extension of the linear-quadratic model to include redistribution and reoxygenationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995